Target intelligence / Profile preview

Catecholamine System (N/A)

Target
N/A
Molecular classification
Neurotransmitter System, Hormone System, Signaling Pathway
01

Overview

The catecholamine system refers to the network of molecules, enzymes, receptors, and physiological processes involving catecholamines—biogenic amines that function as both neurotransmitters and hormones in the body. The primary catecholamines are dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline). These molecules are synthesized from the amino acid tyrosine through a well-defined biosynthetic pathway and regulate numerous physiological functions including heart rate, blood pressure, metabolism, movement, emotional responses, and memory. Alterations in the catecholaminergic system are implicated in various diseases, and blood tests for circulating levels of these molecules help diagnose certain endocrine disorders or monitor stress responses.

Other names
Catecholaminergic SystemDopamine, Norepinephrine, and Epinephrine System
02

Mechanism of action

Drugs targeting the catecholamine system act via various mechanisms, including: (1) influencing catecholamine synthesis, (2) blocking or stimulating catecholamine receptors, (3) inhibiting catecholamine reuptake, or (4) inhibiting catecholamine degradation.

03

Biological functions

NeurotransmissionHormonal regulationRegulation of heart rateRegulation of blood pressureRegulation of metabolismRegulation of movementRegulation of emotional responsesRegulation of memory and reward mechanismsStress response ("fight-or-flight")
04

Disease associations

Parkinson's diseaseHeart failureDepressionHypertensionPheochromocytomaStress-related disorders
05

Safety considerations

Cardiovascular side effects (e.g., arrhythmia, hypertension)Neurological side effects (e.g., anxiety, insomnia, psychosis)Drug interactionsTolerance and dependenceWithdrawal symptoms
06

Interacting drugs

L-DOPA

6 more in the full profile.

07

Biomarkers

Circulating catecholamine levels (dopamine, norepinephrine, epinephrine)Tyrosine hydroxylase activityDopamine beta-hydroxylase activityPhenylethanolamine N-methyltransferase activityLevels of catecholamine metabolites (e.g., VMA, HVA)

Beyond the preview

Go deeper on Catecholamine System (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Catecholamine System (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call